Objectives: To evaluate the prevalence of cardiac injury and its association with mortality in hospitalized patients infected with avian influenza A (H7N9) virus.
Design: Retrospective cohort study.
Setting: A total of 133 hospitals in 17 provinces, autonomous regions, and municipalities of mainland China that admitted influenza A (H7N9) virus-infected patients between January 22, 2015, and June 16, 2017.
Patients: A total of 321 patients with influenza A (H7N9) virus infection were included in the final analysis.
Measurements and main results: Demographics and clinical characteristics were collected from medical records. Cardiac injury was defined according to cardiac biomarkers, electrocardiography, or echocardiography. Among the 321 patients, 203 (63.2%) showed evidence of cardiac injury. Compared with the uninjured group, the cardiac injury group had lower PaO2/FIO2 (median, 102.0 vs 148.4 mm Hg; p < 0.001), higher Acute Physiology and Chronic Health Evaluation II score (median, 17.0 vs 11.0; p < 0.001), longer stay in the ICU (10.0 vs 9.0 d; p = 0.029), and higher proportion of in-hospital death (64.0% vs 20.3%; p < 0.001). The proportion of virus clearance until discharge or death was lower in the cardiac injury group than in the uninjured group (58.6% vs 86.4%; p < 0.001). Multivariable-adjusted Cox proportional hazards regression analysis showed that cardiac injury was associated with higher mortality (hazards ratio, 2.06; 95% CI, 1.31-3.24) during hospitalization.
Conclusions: Cardiac injury is a frequent condition among hospitalized patients infected with influenza A (H7N9) virus, and it is associated with higher risk of mortality.
Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus.Crit Care Med. 2020 Apr;48(4):451-458. doi: 10.1097/CCM.0000000000004207. Crit Care Med. 2020. PMID: 32205590 Free PMC article.
[Design and application of bundle treatment plan in the early stage for severe human infection by avian influenza H7N9].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Jan;30(1):24-28. doi: 10.3760/cma.j.issn.2095-4352.2018.01.005. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29308753 Chinese.
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia.Crit Care Med. 2016 Jun;44(6):e318-28. doi: 10.1097/CCM.0000000000001616. Crit Care Med. 2016. PMID: 26934144
Novel avian-origin influenza A (H7N9) in critically ill patients in China*.Crit Care Med. 2015 Feb;43(2):339-45. doi: 10.1097/CCM.0000000000000695. Crit Care Med. 2015. PMID: 25365721
A review on current trends in the treatment of human infection with H7N9-avian influenza A.J Infect Public Health. 2019 Mar-Apr;12(2):153-158. doi: 10.1016/j.jiph.2018.08.005. Epub 2018 Sep 10. J Infect Public Health. 2019. PMID: 30213468 Review.
Cited by 1 article
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986264 Free PMC article.